Reference
Heath K, et al. Reaching UNAIDS 95-95-95 targets worldwide: predicted benefits and treatment costs with generic manufacture. . AIDS : 9 Jun 2021. Available from: URL: http://doi.org/10.1097/QAD.0000000000002983
Rights and permissions
About this article
Cite this article
What are the minimum costs of HIV drug production that could provide equitable pricing?. PharmacoEcon Outcomes News 881, 34 (2021). https://doi.org/10.1007/s40274-021-7830-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7830-9